-
Alex Kentsis
- Nov 05, 2020
KRG Outreach: Biology and Pharmacology of Childhood and Developmental Cancers
Twitter Feed
Load More...Congratulations to Nai-Kong Cheung and many colleagues on this landmark approval, a target and antibody discovered and developed by decades of research @sloan_kettering #MSKKids https://www.globenewswire.com/news-release/2020/11/25/2134120/0/en/FDA-Approves-Y-mAbs-DANYELZA-naxitamab-gqgk-for-the-Treatment-of-Neuroblastoma.html
Interested in pursuing a PhD in pharmacology? Check out the link to learn more about our program @WeillCornellGS
https://youtu.be/G_TzHbrvnU0Another fascinating paper from Tim Coorens, Sam Behjati and colleagues on developmental origins of predisposed neuroblastoma: https://www.nejm.org/doi/full/10.1056/NEJMoa2000962
The new NCI’s #CPTAC and @CBTNetwork pediatric brain cancer study released today in @CellCellPress provides an excellent source of #proteogenomic data for the NCI’s Childhood Cancer Data Initiative. Read more: https://www.cell.com/cell/fulltext/S0092-8674(20)31451-3 @IcahnMountSinai @theNCI @CHOP @ChildrensNatl
Please watch @paolocifani explain his research on the Quantitative Cancer Proteomics Atlas https://youtu.be/d3_Rph7ERgU
